comparemela.com

Latest Breaking News On - Central drug laboratory - Page 6 : comparemela.com

Spurious drugs: 2 more propofol batches declared substandard

Two more samples of anaesthetic propofol injection, drawn from batches other than the one blamed for five deaths at the PGIMER-Chandigarh recently, have failed the safety test, according to the monthly alert issued today by apex drug regulator Central Drugs Standard Control Organisation (CDSCO). Fou

Kala-amb
Himachal-pradesh
India
Kolkata
West-bengal
Paonta-sahib
Nalagarh
Navneet-marwaha
Ambika-sharma
Regional-drug-testing-lab-in-chandigarh
Central-drug-laboratory
Central-drugs-standard-control-organisation

Four samples of Propofol injections among 21 drugs declared substandard

Four samples of Propofol injections manufactured by Kala Amb-based Nixi Laboratories, including two drawn from the contentious batch which caused five deaths at PGIMER Chandigarh, were declared substandard by the Central Drugs Standard Control Organisation (CDSCO) in the monthly alert issued on Mond

Kala-amb
Himachal-pradesh
India
Kolkata
West-bengal
Himachal
Uttaranchal
Navneet-marwaha
Ambika-sharma
Regional-drug-testing-lab-chandigarh
Drugs-authority
Central-drug-laboratory

Expert committee holds first meeting to examine WHO claims on Maiden Pharma case

As per the tentative results of WHO s evaluation, out of the 23 samples of the products under reference were tested, of which four were found to contain Diethylene Glycol or Ethylene glycol.

India
Sonipat
Haryana
Kolkata
West-bengal
Gambia
Maiden-pharmaceuticals-ltd
Central-drug-laboratory
Atlantic-pharmaceuticals-company-ltd
Maiden-pharmaceuticals
West-africa

Expert committee holds first meeting to examine WHO's claims on Maiden Pharmaceuticals case

The first meeting of the four-membered committee to examine the World Health Organisation s report regarding Maiden Pharmaceuticals Ltd was held on Thursday.

India
Sonipat
Haryana
Kolkata
West-bengal
Gambia
New-delhi
Delhi
Pune
Maharashtra
Pragya-yadav
Maiden-pharmaceuticals-ltd

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.